Copyright
©The Author(s) 2023.
World J Gastroenterol. Mar 7, 2023; 29(9): 1492-1508
Published online Mar 7, 2023. doi: 10.3748/wjg.v29.i9.1492
Published online Mar 7, 2023. doi: 10.3748/wjg.v29.i9.1492
Figure 1 Evolution of the colorectal cancer screening program indicators (target population of the campaigns, number of tests carried out, number and proportion of positive tests, rate of completion of colonoscopy) over the 4 study periods (guaiac fecal occult blood test, fecal immunochemical test, STOP-fecal immunochemical test, and COVID).
The asterisk (*) is the target population at the start of the period. The colonoscopy completion rate was estimated based on data extraction as of January 31, 2022. gFOBT: Guaiac fecal occult blood test; COVID: Coronavirus disease; FIT: Fecal immunochemical test; Nb: Number; CRCSP: Colorectal cancer screening program.
- Citation: Koïvogui A, Vincelet C, Abihsera G, Ait-Hadad H, Delattre H, Le Trung T, Bernoux A, Carroll R, Nicolet J. Supply and quality of colonoscopy according to the characteristics of gastroenterologists in the French population-based colorectal-cancer screening program. World J Gastroenterol 2023; 29(9): 1492-1508
- URL: https://www.wjgnet.com/1007-9327/full/v29/i9/1492.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i9.1492